<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
<channel>
  <title>PRZOOM - Newswire - Free Press Release Distribution - Research</title>
  <link>http://www.przoom.com/</link>
  <description>Recent Research - PRZOOM Press Releases - NewswireToday Headline News - Visit  PRNewswireDistribution.com</description>
  <pubDate>Fri, 25 Jul 2008 03:31:32 -0400</pubDate>
  <category>Research</category>
 <generator>rss20 by http://www.przoom.com/</generator>
 <webMaster>newsfeed_888@przoom.com</webMaster>

<item>
  <photo>images/nophoto.gif</photo>
  <title>Thermo Fisher Scientific Publishes Poster on the Capability of Collision Cell-based ICP-MS</title>
  <description>PRZOOM - Newswire (press release) - 07/21/2008, Holmes Chapel, Cheshire United Kingdom - Thermo Fisher Scientific publishes poster on the capability of collision cell-based ICP-MS to analyze multi-elemental environmental and geological samples (NYSE: TMO)</description>
  <link>http://www.przoom.com/news/37318/</link>
  <pubDate>07/21/2008</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>ISIS Services to Host Interactive Live Videocast at 3rd International Conference on NOTES™</title>
  <description>PRZOOM - Newswire (press release) - 07/08/2008, Berkeley, CA United States - ISIS Services will serve as the host site for a series of procedures that will be videocast to the Palace Hotel at the NOTES Conference. The release discusses the history of NOTES procedures, as well as ISIS' video conferencing capabilities</description>
  <link>http://www.przoom.com/news/36741/</link>
  <pubDate>07/08/2008</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>40-30 Helps CERN Build World’s Most Powerful Particle Accelerator</title>
  <description>PRZOOM - Newswire (press release) - 07/04/2008, London,  United Kingdom - French company 40-30, a specialist in maintenance systems, is working with CERN (European Organisation for Nuclear Research) on the construction of the world’s largest and most powerful particle accelerator</description>
  <link>http://www.przoom.com/news/36604/</link>
  <pubDate>07/04/2008</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>Trevigen Announces A Highly Sensitive Fluorescent One Hour PARP Inhibition Assay</title>
  <description>PRZOOM - Newswire (press release) - 06/20/2008, Arlington, VA United States - Until now, commercially available PARP assay kits required multiple steps and were time consuming. Trevigen overcomes these drawbacks with the release of the HT Fluorescent Homogeneous PARP Inhibition Assay</description>
  <link>http://www.przoom.com/news/35987/</link>
  <pubDate>06/20/2008</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>Apoptosis Offers New Dimension to Cancer Therapeutics and Prospects for Commercial Benefits</title>
  <description>PRZOOM - Newswire (press release) - 06/10/2008, Palo Alto, CA United States - Extensive cancer research reveals more than 90 percent of cancers occur due to genetic mutations</description>
  <link>http://www.przoom.com/news/35407/</link>
  <pubDate>06/10/2008</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>France’s Excellence in Clinical Trials Attracts Top Companies</title>
  <description>PRZOOM - Newswire (press release) - 06/05/2008, London,  United Kingdom - Companies look to France as the centre of excellence for medical and pharmaceutical research, since the effective and well-regulated management of clinical trials in specialist hospitals represents a vital stage in developing new treatments</description>
  <link>http://www.przoom.com/news/35237/</link>
  <pubDate>06/05/2008</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>Trevigen Releases the First Standardized 3-D Culture Cell Harvesting Kit</title>
  <description>PRZOOM - Newswire (press release) - 05/22/2008, Arlington, VA United States - Trevigen releases the first standardized kit for isolating cells from 3-D Culture for biochemical analysis. The Cultrex® 3-D Culture Cell Haversting Kit is based on a nonenzymatic approach which prevents biochemical degradation during processing</description>
  <link>http://www.przoom.com/news/34595/</link>
  <pubDate>05/22/2008</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>Life Sciences Research Moving Towards Excellence in Europe</title>
  <description>PRZOOM - Newswire (press release) - 05/15/2008, London,  United Kingdom - Life sciences funding is witnessing unprecedented increases in recent years, pressuring the EU to keep pace with the United States. The cohesion of research policies and funding channels across Europe will be necessary to achieve this objective</description>
  <link>http://www.przoom.com/news/34220/</link>
  <pubDate>05/15/2008</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>CureKids Hires Executive Director &amp; CEO – Launching its USA Operations</title>
  <description>PRZOOM - Newswire (press release) - 04/30/2008, Hingham, MA United States - Alan Kinniburgh to head Children’s Medical Research Organization</description>
  <link>http://www.przoom.com/news/33517/</link>
  <pubDate>04/30/2008</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>Catherine Bruederle to Present at GTCbio’s Assay Development &amp; Screening Technologies Conference</title>
  <description>PRZOOM - Newswire (press release) - 04/27/2008, Monrovia, CA United States - Dr. Bruederle will present on two different strategies in assay discovery using conformation-dependent protein interactions and pH sensitive dyes for sensitive cell-based detection</description>
  <link>http://www.przoom.com/news/33053/</link>
  <pubDate>04/27/2008</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>$1M in New Grants Awarded to Further Melanoma Research in 2008</title>
  <description>PRZOOM - Newswire (press release) - 04/02/2008, Washington, DC United States - The Melanoma Research Foundation (MRF) recently approved 2008 grants through the MRF Research Grant Program totaling more than $1 million, providing a substantial boost to the melanoma research community</description>
  <link>http://www.przoom.com/news/32172/</link>
  <pubDate>04/02/2008</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>'Chemicals Feed Hopes and Fears' - Covalence Chemical Industry Report 2007</title>
  <description>PRZOOM - Newswire (press release) - 03/12/2008, Geneva,  Switzerland - Without their products chemical companies would be praised as ethical leaders</description>
  <link>http://www.przoom.com/news/31229/</link>
  <pubDate>03/12/2008</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>Research of Patients and Physicians About Drug Delivery Technologies in the U.S. Produces Exciting New Study</title>
  <description>PRZOOM - Newswire (press release) - 03/04/2008, Palo Alto, CA United States - Recent patient and physician research conducted by Frost &amp; Sullivan's Pharmaceutical/Biotechnology Group generates a new end user study on the preferences and drivers of adoption for various drug delivery technologies in the U.S. pharmaceutical market</description>
  <link>http://www.przoom.com/news/30851/</link>
  <pubDate>03/04/2008</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>Device Lessens Negative Effects of Stem Cell Transplants Says General BioTechnology Expert</title>
  <description>PRZOOM - Newswire (press release) - 02/01/2008, Indianapolis, IN United States - Biotech company creates device that filters out harmful effects of cryoprotectant</description>
  <link>http://www.przoom.com/news/29308/</link>
  <pubDate>02/01/2008</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>The Solution for Contract Research Organizations Market Information Needs</title>
  <description>PRZOOM - Newswire (press release) - 10/15/2007, Palo Alto, CA United States - New analysis from Frost &amp; Sullivan titled Global CRO Spending Trends provides detailed revenue forecasts for the CRO markets and key trends in R&amp;D spending and clinical trials</description>
  <link>http://www.przoom.com/news/24743/</link>
  <pubDate>10/15/2007</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>Advances in Drug Discovery Technologies Fuelling Development of Anti-Diabetic Therapies</title>
  <description>PRZOOM - Newswire (press release) - 09/25/2007, Palo Alto, CA United States - Rising knowledge of metabolic pathways at genetic, cellular, and molecular levels is giving rise to more focused molecular drug targets, reports a new analysis from Frost &amp; Sullivan</description>
  <link>http://www.przoom.com/news/23898/</link>
  <pubDate>09/25/2007</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>ReachBio, LLC Launched by Experienced Stem Cell Management Team</title>
  <description>PRZOOM - Newswire (press release) - 09/18/2007, Seattle, WA United States - ReachBio, LLC will provide in vivo and in vitro assays for bone marrow toxicity, engraftment kinetics, and related applications</description>
  <link>http://www.przoom.com/news/23620/</link>
  <pubDate>09/18/2007</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>Opportunities in New Applications Drives Strong Growth of U.S. Liquid Chromatography Markets</title>
  <description>PRZOOM - Newswire (press release) - 08/22/2007, Palo Alto, CA United States - New analysis from Frost &amp; Sullivan, U.S. Liquid Chromatography Markets, finds that these markets earned revenues of $596.3 million in 2006 and estimates this to reach $1.018 billion in 2013</description>
  <link>http://www.przoom.com/news/22602/</link>
  <pubDate>08/22/2007</pubDate>
  <category>Research</category>
</item>

</channel>
</rss>